Treatment with tofersen in patients with superoxide 1 dismutase 1 ALS was linked to preservation of motor function, maintenance of muscle strength and reduction of disease-specific biomarkers, data show. “Mutations in SOD1, the gene encoding superoxide 1 dismutase-1 (SOD1), are present in 1% to 2% of all amyotrophic lateral sclerosis patients,” Sean E. Smith, MD, MPHS,
Robert Herpen is an Online Content Editor at Healio. He focuses on a range of themes including medicine and healthcare, alternative medicine, diagnostics, and wellness, with an emphasis on social issues, the coronavirus, AI, cannabis, and data. Robert is featured in Healio, where he contributes to discussions on pressing health topics and trends.